Sangamo BioSciences | SGMO - Passività Correnti

Prezzo Delle Azioni
0.25
Cambio Giornaliero
-0.01 -4.09%
Mensile
-38.64%
Annuale
-65.04%
Q2 Previsione
0.24




Passività Correnti Cambiamento Data
Alaunos Therapeutics USD 921K 153K 2025-09
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Bayer EUR 32.58B 3.63B 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Cipla INR 62.97B 8.13B 2025-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.57M 2.29M 2025-12
CSL USD 4.61B 207M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Grifols EUR 2.37B 156.97M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
J&J USD 54.13B 3.26B 2025-12
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Merck USD 28.63B 2.59B 2025-09
Novartis USD 27.28B 4.72B 2025-12
Omeros USD 85.5M 2.28M 2025-06
Pfizer USD 36.6B 1.13B 2025-09
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 3.76B 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12